Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12,733,410
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
1,731,697
-
Shares change
-
+158,647
-
Total reported value, excl. options
-
$26,254,559
-
Value change
-
+$2,439,990
-
Number of buys
-
15
-
Number of sells
-
-9
-
Price
-
$15.15
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q4 2017
38 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q4 2017.
IRADIMED CORP - Common Stock (IRMD) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,731,697 shares
of 12,733,410 outstanding shares and own 13.6% of the company stock.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (467,982 shares), Mondrian Investment Partners LTD (206,547 shares), Vanguard Group Inc (185,215 shares), Granite Investment Partners, LLC (99,238 shares), Menta Capital LLC (66,976 shares), AQR CAPITAL MANAGEMENT LLC (62,294 shares), Eversept Partners, LP (51,059 shares), RENAISSANCE TECHNOLOGIES LLC (47,770 shares), Boston Partners (44,321 shares), and BlackRock Inc. (43,224 shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.